Literature DB >> 7689195

Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population.

K Hyland1, R A Surtees, S J Heales, A Bowron, D W Howells, I Smith.   

Abstract

Accurate diagnosis and management of inborn errors of monoamine neurotransmitter and tetrahydrobiopterin metabolism depend on reliable reference ranges of key metabolites. Cerebrospinal fluid (CSF) was collected in a standardized way from 73 children and young adults with neurologic disease, with strict exclusions. In each specimen, concentrations of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (HIAA), total neopterin, 7,8-dihydrobiopterin, and tetrahydrobiopterin (BH4) were measured using HPLC. There was a continuous decrement in CSF HVA, HIAA, and BH4 during the first few years of life; this was independent of height (or length). Age-related reference ranges for each metabolite are given. Extensive correlations between HVA, HIAA, 7,8-dihydrobiopterin, and BH4 were further analyzed by multiple regression. Age and CSF BH4 were significant explanatory variables for CSF HIAA, but CSF HVA had only HIAA as a significant explanatory variable.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689195     DOI: 10.1203/00006450-199307000-00003

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  29 in total

1.  Cerebrospinal fluid nitrite plus nitrate correlates with tetrahydrobiopterin concentration.

Authors:  S J Heales; L Canevari; M P Brand; J B Clark; J M Land; K Hyland
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

Review 2.  Tetrahydrobiopterin as a novel therapeutic intervention for autism.

Authors:  Richard E Frye; Lynne C Huffman; Glen R Elliott
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

3.  Simultaneous determination of all forms of biopterin and neopterin in cerebrospinal fluid.

Authors:  Pierre Guibal; Nathalie Lévêque; Diane Doummar; Nicolas Giraud; Emmanuel Roze; Diana Rodriguez; Rémy Couderc; Thierry Billette De Villemeur; Fathi Moussa
Journal:  ACS Chem Neurosci       Date:  2014-04-08       Impact factor: 4.418

4.  Proceedings of the 10th Asian Pacific Congress of Clinical Biochemistry in conjunction with the Australasian Association of Clinical Biochemists' 42nd Annual Scientific Conference.

Authors: 
Journal:  Clin Biochem Rev       Date:  2004

5.  Decreased cerebral spinal fluid neurotransmitter levels in Smith-Lemli-Opitz syndrome.

Authors:  S E Sparks; C A Wassif; H Goodwin; S K Conley; D C Lanham; L E Kratz; K Hyland; A Gropman; E Tierney; F D Porter
Journal:  J Inherit Metab Dis       Date:  2014-02-06       Impact factor: 4.982

Review 6.  Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology.

Authors:  Linda Booij; Richard E Tremblay; Moshe Szyf; Chawki Benkelfat
Journal:  J Psychiatry Neurosci       Date:  2015-01       Impact factor: 6.186

Review 7.  Monoamine neurotransmitter disorders--clinical advances and future perspectives.

Authors:  Joanne Ng; Apostolos Papandreou; Simon J Heales; Manju A Kurian
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

8.  Normal Cerebrospinal Fluid Pyridoxal 5'-Phosphate Level in a PNPO-Deficient Patient with Neonatal-Onset Epileptic Encephalopathy.

Authors:  Alina Levtova; Stephane Camuzeaux; Anne-Marie Laberge; Pierre Allard; Catherine Brunel-Guitton; Paola Diadori; Elsa Rossignol; Keith Hyland; Peter T Clayton; Philippa B Mills; Grant A Mitchell
Journal:  JIMD Rep       Date:  2015-03-12

9.  Neurotransmitter metabolites in CSF: an external quality control scheme.

Authors:  C Bräutigam; C Weykamp; G F Hoffmann; R A Wevers
Journal:  J Inherit Metab Dis       Date:  2002-08       Impact factor: 4.982

10.  Serotonin metabolites in the cerebrospinal fluid in sudden infant death syndrome.

Authors:  Ingvar J Rognum; Hoa Tran; Elisabeth A Haas; Keith Hyland; David S Paterson; Robin L Haynes; Kevin G Broadbelt; Brian J Harty; Othon Mena; Henry F Krous; Hannah C Kinney
Journal:  J Neuropathol Exp Neurol       Date:  2014-02       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.